NEW YORK (GenomeWeb) – Stem cell products and services provider Definigen said today it will validate induced pluripotent stem cells for the European Bank for Induced Pluripotent Stem Cells (EBiSC) consortium.

EBiSC is a 26-partner public-private European initiative coordinated by Pfizer and managed by Roslin Cells that will store and distribute iPS cells to global research communities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.